EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur(R), a Novel Extended-Release Opioid Analgesic for Post Operative Pain CEDAR KNOLLS, ...

EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur, a Novel Extended-Release Opioid Analgesic for Post Operative Pain CEDAR KNOLLS, ...

Cornerstone Therapeutics (NASDAQ:CRTX) has reached a preliminary agreement to acquire acute-care hospital products company EKR Therapeutics and the rights to two of its drugs in a deal valued at up to ...

A few months ago, I wrote about the intriguing trend toward “re-launching” biotech startups that had been recently acquired by Big Pharma or Big Biotech — minus, of course, whatever promising drug ...

NEW YORK (AP) -- Cornerstone Therapeutics Inc. said Wednesday it completed its $125 million purchase of specialty drugmaker EKR Therapeutics. Cornerstone agreed to buy EKR in May. The deal gives it ...

EKR Therapeutics, Inc., a specialty pharmaceutical company in Cedar Knolls focused on acquiring acute-care products, today announced that its co-founder and chief financial officer, Richard DeSimone, ...

Rolf A. Classon, chairman of the board and independent director of EKR Therapeutics, a privately held specialty pharmaceutical company, has resigned effective immediately and will not stand for ...

BEDMINSTER, N.J. A privately held specialty pharmaceutical company announced that the founder and former chairman of Dendrite International has joined its company. EKR Therapeutics said John Bailye ...